| Keyword search (4,163 papers available) | ![]() |
"Tissot C" Authored Publications:
| Title | Authors | PubMed ID | |
|---|---|---|---|
| 1 | Alzheimer's Imaging Consortium | Soucy JP; Belasso CJ; Cai Z; Bezgin G; Stevenson J; Rahmouni N; Tissot C; Lussier FZ; Rosa-Neto P; Rivaz HJ; Benali H; | 39782975 CONCORDIA |
| 2 | Biomarkers | Soucy JP; Belasso CJ; Cai Z; Bezgin G; Stevenson J; Rahmouni N; Tissot C; Lussier FZ; Rosa-Neto P; Rivaz HJ; Benali H; | 39784152 CONCORDIA |
| 3 | Bayesian workflow for the investigation of hierarchical classification models from tau-PET and structural MRI data across the Alzheimer's disease spectrum | Belasso CJ; Cai Z; Bezgin G; Pascoal T; Stevenson J; Rahmouni N; Tissot C; Lussier F; Rosa-Neto P; Soucy JP; Rivaz H; Benali H; | 37920382 PERFORM |
| 4 | Topographical distribution of Aβ predicts progression to dementia in Aβ positive mild cognitive impairment | Pascoal TA, Therriault J, Mathotaarachchi S, Kang MS, Shin M, Benedet AL, Chamoun M, Tissot C, Lussier F, Mohaddes S, Soucy JP, Massarweh G, Gauthier S, Rosa-Neto P, | 32582834 PERFORM |
| Title: | Topographical distribution of Aβ predicts progression to dementia in Aβ positive mild cognitive impairment | ||||
| Authors: | Pascoal TA, Therriault J, Mathotaarachchi S, Kang MS, Shin M, Benedet AL, Chamoun M, Tissot C, Lussier F, Mohaddes S, Soucy JP, Massarweh G, Gauthier S, Rosa-Neto P | ||||
| Link: | https://pubmed.ncbi.nlm.nih.gov/32582834/?utm_source=MS-Office&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1deGMjvjVspk9gsE | ||||
| DOI: | 10.1002/dad2.12037 | ||||
| Publication: | Alzheimer' s & dementia (Amsterdam, Netherlands) | ||||
| Keywords: | Alzheimer'; s disease; amyloid beta; mild cognitive impairment; positron emission tomography; | ||||
| PMID: | 32582834 | Category: | Date Added: | 2020-06-25 | |
| Dept Affiliation: |
PERFORM
1 Translational Neuroimaging Laboratory Alzheimer's Disease Research Unit The McGill University Research Centre for Studies in Aging McGill University Montreal Quebec Canada. 2 Department of Neurology and Neurosurgery McGill University Montreal Quebec Canada. 3 Montreal Neurological Institute Montreal Quebec Canada. 4 PERFORM Centre Concordia University Montreal Quebec Canada. |
||||
Description: |
INTRODUCTION: Abnormal brain amyloid beta (Aß) is typically assessed in vivo using global concentrations from cerebrospinal fluid and positron emission tomography (PET). However, it is unknown whether the assessment of the topographical distribution of Aß pathology can provide additional information to identify, among global Aß positive individuals, those destined for dementia. |



